Tyra Biosciences, Inc.TYRANASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P52
Within normal range
vs 3Y Ago
-2.9x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -5.56% |
| Q3 2025 | 5.49% |
| Q2 2025 | 6.98% |
| Q1 2025 | -29.95% |
| Q4 2024 | -9.45% |
| Q3 2024 | -74.48% |
| Q2 2024 | 53.43% |
| Q1 2024 | -62.78% |
| Q4 2023 | 21.07% |
| Q3 2023 | -78.32% |
| Q2 2023 | 2.36% |
| Q1 2023 | 17.80% |
| Q4 2022 | 1.90% |
| Q3 2022 | 28.87% |
| Q2 2022 | -92.36% |
| Q1 2022 | 1.14% |
| Q4 2021 | -61.85% |
| Q3 2021 | -25.04% |
| Q2 2021 | 4.64% |
| Q1 2021 | -84.90% |
| Q4 2020 | -19.62% |
| Q3 2020 | -29.60% |
| Q2 2020 | -9.83% |
| Q1 2020 | 0.00% |